N-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide
|
- $207 - $1018
- Product name: N-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide
- CAS: 1261365-46-1
- MF: C12H13F3N2O2
- MW: 274.24
- EINECS:
- MDL Number:MFCD18374099
- Synonyms:N-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide;N-[3-formyl-5-(trifluoromethyl)pyridin-2-yl]-2,2-dimethylpropanamide;Propanamide, N-[3-formyl-5-(trifluoromethyl)-2-pyridinyl]-2,2-dimethyl-
10 prices
Selected condition：
Brand
- aablocks
- AK Scientific
- Anichem
- Chemenu
- Crysdot
- Matrix Scientific
- TRC
Package
- 50mg
- 100mg
- 250.00mg
- 250mg
- 0.5g
- 1g
- Manufactureraablocks
- Product numberAA009WWR
- Product descriptionN-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide 95%
- Packaging100mg
- Price$207
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA009WWR
- Product descriptionN-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide 95%
- Packaging250mg
- Price$407
- Updated2026-05-28
- Buy
- ManufacturerAK Scientific
- Product numberZ9042
- Product descriptionN-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide
- Packaging100mg
- Price$291
- Updated2021-12-16
- Buy
- ManufacturerAnichem
- Product numberXZ4099
- Product descriptionN-[3-formyl-5-(trifluoromethyl)pyridin-2-yl]-2,2-dimethylpropanamide >95%
- Packaging0.5g
- Price$560
- Updated2026-05-24
- Buy
- ManufacturerChemenu
- Product numberCM319081
- Product descriptionN-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide 95%
- Packaging1g
- Price$959
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11311173
- Product descriptionN-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide 95+%
- Packaging1g
- Price$1018
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11311173
- Product descriptionN-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide 95+%
- Packaging1g
- Price$1018
- Updated2026-05-26
- Buy
- ManufacturerMatrix Scientific
- Product number059435
- Product descriptionN-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide
- Packaging250mg
- Price$418
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number059435
- Product descriptionN-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide
- Packaging250.00mg
- Price$418
- Updated2026-05-18
- Buy
- ManufacturerTRC
- Product numberF701560
- Product descriptionN-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide
- Packaging50mg
- Price$210
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA009WWR | N-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide 95% | 100mg | $207 | 2026-05-28 | Buy |
| aablocks | AA009WWR | N-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide 95% | 250mg | $407 | 2026-05-28 | Buy |
| AK Scientific | Z9042 | N-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide | 100mg | $291 | 2021-12-16 | Buy |
| Anichem | XZ4099 | N-[3-formyl-5-(trifluoromethyl)pyridin-2-yl]-2,2-dimethylpropanamide >95% | 0.5g | $560 | 2026-05-24 | Buy |
| Chemenu | CM319081 | N-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide 95% | 1g | $959 | 2021-12-16 | Buy |
| Crysdot | CD11311173 | N-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide 95+% | 1g | $1018 | 2021-12-16 | Buy |
| Crysdot | CD11311173 | N-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide 95+% | 1g | $1018 | 2026-05-26 | Buy |
| Matrix Scientific | 059435 | N-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide | 250mg | $418 | 2021-12-16 | Buy |
| Matrix Scientific | 059435 | N-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide | 250.00mg | $418 | 2026-05-18 | Buy |
| TRC | F701560 | N-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide | 50mg | $210 | 2021-12-16 | Buy |
Properties
Boiling point :393.2±42.0 °C(Predicted)
Density :1.302±0.06 g/cm3(Predicted)
pka :12.59±0.70(Predicted)
Density :1.302±0.06 g/cm3(Predicted)
pka :12.59±0.70(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|